Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Krystal Biotech (KRYS) and Veeva Systems (VEEV)
Krystal Biotech Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target
Krystal Biotech Analyst Ratings
Maintaining Buy Rating on Krystal Biotech: Strong VYJUVEK Sales and Promising Pipeline Despite EPS Miss
Krystal Biotech Analyst Ratings
Krystal Biotech Analyst Ratings
Krystal Biotech Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)
Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity
Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)
Krystal Biotech Analyst Ratings
Goldman Sachs Initiates Coverage On Krystal Biotech With Buy Rating, Announces Price Target of $160
Krystal Biotech Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Krystal Biotech, Maintains $160 Price Target
Krystal Biotech Analyst Ratings
Analysts Conflicted on These Healthcare Names: Cigna (CI), Krystal Biotech (KRYS) and MacroGenics (MGNX)
Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS), Shockwave Medical (SWAV) and ACADIA Pharmaceuticals (ACAD)
Analysts Are Bullish on Top Healthcare Stocks: Keros Therapeutics (KROS), Krystal Biotech (KRYS)